Currently out of the existing stock ratings of Ross Muken, 91 are a BUY (59.48%), 52 are a HOLD (33.99%), 10 are a SELL (6.54%).

Ross Muken

Work Performance Price Targets & Ratings Chart

Analyst Ross Muken, currently employed carries an average stock price target met ratio of 88.75% that have a potential upside of 15.48% achieved within 356 days. Previously, Ross Muken worked at EVERCORE.

Ross Muken’s has documented 262 price targets and ratings displayed on 26 stocks. The coverage was on Healthcare, Financial Services sectors.

Most recent stock forecast was given on PDCO, Patterson Companies at 08-Oct-2024.

Wall Street Analyst Ross Muken

Analyst best performing recommendations are on MDRX (ALLSCRIPTS HEALTHCARE SOLUTIONS).
The best stock recommendation documented was for ATHN (ATHENAHEALTH) at 10/14/2013. The price target of $118 was fulfilled within 4 days with a profit of $8.13 (7.4%) receiving and performance score of 18.5.

Average potential price target upside

of $27.26 (19.01%) on MCK (MCKESSON).
of $21.69 (10.53%) on ILMN (ILLUMINA).
of $19.82 (34.29%) on CVS (CVS HEALTH CORP).

DGX Quest Diagnostics orporated ICLR ICON PLC MCK McKesson PDCO Patterson Companies RAD Rite Aid A Agilent Technologies ABC AmerisourceBergen ATHN athenahealth CAH Cardinal Health HSIC Henry Schein WBA Walgreens Boots Alliance CERN Cerner Corp ILMN Illumina IQV IQVIA Holdings LH Laboratory of America Holdings Q Quintiles Transnational QGEN Qiagen NV TMO Thermo Fisher Scientific TWST Twist Bioscience Corp EHTH eHealth CRL Charles River Laboratories CVS CVS Health Corp DHR Danaher MDRX Allscripts Healthcare Solutions PINC Premier WAT Waters

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Derik De Bruin (BAML)